Skip to content

Conventures: what changed

BE 1017.838.420NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved

Only one financial year

Comparing needs two financial years with figures read. This company has one.

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€246,326 to €246,326

Midpoint €246,326 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €246,326
Indication €246,326

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€246,326
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€246,326

Capitalised earnings

net result for the year (9904)
2025
-€3,674
Average result
-€3,674
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.